BEAM-301

· Beam Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BEAM-301, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa) [Phase 1, Phase 2]

See pricing